Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NOURIANZ safely and effectively. See full prescribing information for NOURIANZ. NOURIANZ® (istradefylline) tablets, for oral use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
NOURIANZ is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes.
- generic_name
- istradefylline
- product_names
- istradefylline
- ndc
- 42747-602, 42747-602-90, 42747-602-07, 42747-604, 42747-604-90, 42747-604-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en